Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
One market research firm said even duties in the range of 15%-30% won’t keep most of the country’s carmakers out of Europe.
The brewer is reportedly in early talks to sell to Japan’s Suntory, which owns American spirits brands Jim Beam and Maker’s Mark.
The big services are working on a structure that will weigh factors such as viewership time, production budget, and new subscriptions added.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
The FAA won’t clear the current production cap and plans to approve every single plane that comes off Boeing’s production lines.
As juice-sucking tech firms battle for artificial intelligence supremacy, the coal industry has been cleaning up.
The deal provides increased operations both outside of and within the highly desirably Permian Basin oil fields of Western Texas.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
Ford filed two patents to make EV charging adoption quicker, cheaper and easier.
Toyota is partnering with petroleum firms to develop carbon-neutral fuels and make them available in Japan by 2030.
PayPal is harnessing purchase data to join the ever-growing list of companies with a new offshoot advertising business.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.